6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, V; Babula, P; Eckschlager, T; Gumulec, J; Hlavna, M; Hrabec, R; Kizek, R; Krizkova, S; Masarik, M; Rovny, A; Sochor, J; Sztalmachova, M | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Caveolin-1 as a potential high-risk prostate cancer biomarker.
Topics: Aged; Antioxidants; Biomarkers, Tumor; Biphenyl Compounds; Caveolin 1; Chromans; Chromium Compounds; Free Radicals; Glutathione; Humans; Male; Middle Aged; Oxidative Stress; Peroxides; Picrates; Prostatic Neoplasms | 2012 |